Follow us on:
Dedication / Services
To provide 50000 services and products to global scientific research units every year

pagibaximab

DESCRIPTION CATALOG # SIZE PRICE
Anti-S. epidermidis LTA Therapeutic Antibody TAB-H53 1mg Please Inquiry
Product Detail
Cat
TAB-H53
Product Overview
Recombinant Chimeric (human/mouse) antibody to S. epidermidis LTA. Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.
Type
IgG1 - kappa
Species Reactivity
S. epidermidis
Expression Host
CHO
Applications
Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, WB and most other immunological methods.
CAS
595566-61-3
Specificity
Staphylococcus epidermidis lipoteichoic acid [Staphylococcus epidermidis]
Protein Construction
immunoglobulin G1, anti-(Staphylococcus epidermidis lipoteichoic acid)(human-mouse monoclonal heavy chain), disulfide with human- mousemonoclonal κ-chain, dimer
Purity
>95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.
Background
Introduction
Lipoteichoic acid (LTA) is a major constituent of the cell wall of Gram-positive bacteria. These organisms have an inner (or cytoplasmic) membrane and, external to it, a thick (up to 80 nanometer) peptidoglycan layer. The structure of LTA varies between the different species of Gram positive bacteria and may contain long chains of ribitol or glycerol phosphate.
Keywords
Lipoteichoic acid; LTA; S. epidermidis LTA; Staphylococcus epidermidis lipoteichoic acid
Download Datasheet:

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
Loading...
Contact Us

USA
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email: 

Europe
Tel: 44-207-048-3343


© 2007 - 2017 Creative-Biolabs All Rights Reserved